-
7-Ethyl-10-hydroxycamptothecin: High-Purity DNA Topoisome...
2026-01-21
7-Ethyl-10-hydroxycamptothecin (SN-38) is a high-purity DNA topoisomerase I inhibitor with a proven IC50 of 77 nM, optimized for in vitro colon cancer research. It induces S-phase and G2-phase cell cycle arrest and apoptosis in metastatic colon cancer cell lines. This article details its mechanism, application parameters, and benchmarks for translational oncology workflows.
-
WY-14643 (Pirinixic Acid): Strategic Agonism at the Front...
2026-01-20
This thought-leadership article provides translational researchers with a mechanistic, evidence-driven roadmap for deploying WY-14643 (Pirinixic Acid) in advanced metabolic disorder and inflammation studies. We synthesize biological rationale, recent experimental evidence, and strategic guidance to propel your research beyond current paradigms, while critically referencing cutting-edge multiomics findings and APExBIO’s commitment to reliable, next-generation research tools.
-
Sodium Picosulfate (SKU B2027): Reliable Solutions for Ce...
2026-01-20
This article delivers practical, scenario-driven insights into how Sodium Picosulfate (SKU B2027) from APExBIO addresses persistent laboratory challenges in cell viability, cytotoxicity, and gastrointestinal motility research. By grounding recommendations in quantitative data, peer-reviewed literature, and explicit product characteristics, it equips biomedical researchers, lab technicians, and postgraduates with validated strategies for reproducible and efficient workflows.